PATRICK J. ZENNER

Corporate Board Profile

Tech Score: 0/100

GERON CORP

Filing Date	Source Excerpt
2009-04-10	Patrick J. Zenner has served as a director of the Company since July 2001. For part of 2007, Mr. Zenner served as interim Chief Executive Officer of Exact Sciences Corporation, a genomics-based biopharmaceutical company, and served as interim Chief Executive Officer for CuraGen Corporation from May 2005 through March 2006. From 1969 until January 2001, Mr. Zenner held a series of executive managerial positions with Hoffmann La-Roche, Inc., North America, the prescription drug unit of the Roche Group, a leading research-based health care enterprise. He retired as President and Chief Executive Officer in January 2001. He is also a director of Arqule, Inc., CuraGen Corporation, Exact Sciences Corporation, XOMA Ltd. and West Pharmaceutical Services. Mr. Zenner holds a B.S.B.A. from Creighton University and a M.B.A. from Fairleigh Dickinson University. He serves on the Board of Trustees for both universities and is Chairman of the board of directors for Fairleigh Dickinson University.

Filing Date

Source Excerpt

2009-04-10

Patrick J. Zenner has served as a director of the Company since July 2001. For part of 2007, Mr. Zenner served as interim Chief Executive Officer of Exact Sciences Corporation, a genomics-based biopharmaceutical company, and served as interim Chief Executive Officer for CuraGen Corporation from May 2005 through March 2006. From 1969 until January 2001, Mr. Zenner held a series of executive managerial positions with Hoffmann La-Roche, Inc., North America, the prescription drug unit of the Roche Group, a leading research-based health care enterprise. He retired as President and Chief Executive Officer in January 2001. He is also a director of Arqule, Inc., CuraGen Corporation, Exact Sciences Corporation, XOMA Ltd. and West Pharmaceutical Services. Mr. Zenner holds a B.S.B.A. from Creighton University and a M.B.A. from Fairleigh Dickinson University. He serves on the Board of Trustees for both universities and is Chairman of the board of directors for Fairleigh Dickinson University.

WEST PHARMACEUTICAL SERVICES INC

Filing Date	Source Excerpt
2014-03-25	Patrick J. Zenner Age: 67 Director since 2002 Committees: Nominating & Corp. Gov., Compensation 2013 Non-Employee Director Compensation Patrick J. Zenner Fees Earned or Paid in Cash: 70,000 Stock Awards: 130,015 All Other Compensation: 18,972 Total: 218,987
2015-03-24	Patrick J. Zenner Age: 68 Committees: Lead, Independent Director, Nominating & Corp. Gov., Succession Planning 2014 Non-Employee Director Compensation: Total $241,774 Mr. Zenner is retired from Hoffmann-La Roche Inc., North America.
2016-03-23	Patrick J. Zenner Age: 69 Director since 2002 Chairman since 2015 Committees: Nominating & Corp. Gov. Mr. Zenner was elected Chairman of the Board effective July 1, 2015. ... 2015 Non-Employee Director Compensation ... Patrick J. Zenner Fees Earned or Paid in Cash: 127,526 Stock Awards: 130,000 All Other Compensation: 24,365 Total: 281,891
2017-03-22	Patrick J. Zenner Age: 70 Director since 2002 Chairman since 2015 Committees: Nominating & Corp. Gov. Mr. Zenner was elected Chairman of the Board effective July 1, 2015. ... 2016 Non-Employee Director Compensation Patrick J. Zenner Fees Earned or Paid in Cash: 128,539 Stock Awards: 160,000 All Other Compensation: 26,552 Total: 315,091
2018-03-21	Patrick J. Zenner Age: 71 Director since 2002 Chairman since 2015 Committees: Nominating & Corp. Gov. Mr. Zenner was elected Chairman of the Board effective July 1, 2015. He retired from Hoffmann-La Roche Inc., North America – the prescription drug unit of the Roche Group, a leading research-based healthcare enterprise – in 2001, where he served as President and Chief Executive Officer from 1993 to 2001. 2017 Non-Employee Director Compensation Patrick J. Zenner Fees Earned or Paid in Cash ($): 130,000 Stock Awards ($): 209,751 All Other Compensation ($): 28,676 Total ($): 368,427
2019-03-22	Mr. Zenner was elected Chairman of the Board effective July 1, 2015... Mr. Zenner possesses more than 40 years of experience and expertise in the pharmaceutical industry... As the lead independent director for West, Mr. Zenner has served in a number of leadership roles, including membership on each of the Company's board committees... The continuity of his membership and length of service on the Board is a valuable asset...
2020-03-25	Mr. Zenner was first elected Chair of the Board effective July 1, 2015... Mr. Zenner possesses more than 40 years of experience and expertise in the pharmaceutical industry... As the lead independent director for West, Mr. Zenner has served in several leadership roles, including membership on each of the Company's board committees.
2021-03-24	Mr. Zenner was first elected Chair of the Board effective July 1, 2015... He serves as Chair of the Board and on the Nominating and Corporate Governance Committee. 2020 Non-Employee Director Compensation: $453,214.

Data sourced from SEC filings. Last updated: 2026-02-03